83
7
220
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10863 |
Complement C5-IN-1
|
Complement System | Immunology/Inflammation |
Complement C5-IN-1 (Compound 7) 是补体成分蛋白5 (C5) 的小分子抑制剂。 Complement C5-IN-1 与 C5 相互作用以防止其被 C5 转化酶切割, 阻断酵母多糖诱导的 50%人全血 MAC 沉积的 IC50 值为 0.77 μM。 | |||
T38332 |
Complement factor D-IN-2
|
Complement System | Immunology/Inflammation |
Complement factor D-IN-2 是 omplement factor D 的有效抑制剂,在替代补体途径的早期和关键时刻靶向 factor D 并抑制补体级联反应。Complement factor D-IN-2在自身免疫疾病的方面有研究的价值。 | |||
T7497L |
C3a 70-77 2TFA(63555-63-5(free base))
Complement 3a (70-77) |
Complement System | Immunology/Inflammation |
C3a 70-77 2TFA(63555-63-5(free base)) (Complement 3a (70-77)) 是对应于 C3a 的 COOH 末端的八肽。 | |||
T38287 |
C3a Receptor Agonist
C3a receptor agonist 1,C3a受体激动剂,Complement 3a Receptor Agonist |
Complement System | Immunology/Inflammation |
C3a Receptor Agonist (C3a receptor agonist 1) 结合免疫系统补体途径中的G 蛋白偶联C3a 受体(C3aRs)。在肠缺血再灌注损伤模型中,C3aR 的激活可防止中性粒细胞动员。C3aRs 在成年小鼠的神经祖细胞和未成熟神经元上表达。C3a 在体外刺激神经祖细胞的分化。 | |||
T16898 |
Complement factor D-IN-1
|
Others | Others |
Complement factor D-IN-1 is an effective and selective small-molecule reversible factor d inhibitor (IC50s: 0.006 and 0.05 μM in FD Thioesterolytic Fluorescent Assay and a MAC Deposition Assay, respectively). | |||
T80059 |
Complement factor I
|
Endogenous Metabolite | Metabolism |
Complement factor I,一丝氨酸蛋白酶,可与辅助因子H (FH)、补体受体1 (CR1/CD35)、C4结合蛋白 (C4BP) 或膜辅助因子蛋白 (MCP/CD46) 结合,调控液相及/或细胞表面补体系统的活性。 | |||
T74816 | Complement C1s-IN-1 | ||
Complement C1s-IN-1 是一种有效的、选择性的、具有口服活性并可穿过血脑屏障的C1s 抑制剂,IC50值为 36 nM。 | |||
T9915 | Eculizumab | Complement System | Immunology/Inflammation |
Eculizumab 是针对补体 C5 的长效人源化单克隆抗体。它对 C5 裂解为 C5a 和 C5b 具有抑制作用,并抑制了末端补体系统的部署,其中包括膜攻击复合物的形成。它可用于溶血的研究。 | |||
T7497 |
C3a (70-77)
Complement 3a (70-77),C3a 70-77 |
Complement System | Immunology/Inflammation |
C3a (70-77) 是对应于 C3a 的 COOH 末端的八肽。 | |||
TP1304 |
Compstatin
坎普他汀 |
Complement System | Immunology/Inflammation |
Compstatin 是一种环状十三肽,是补体系统 C3的特异性抑制剂。它只抑制灵长类补体系统的激活,可结合到狒狒的 C3,并对狒狒血液中的蛋白水解裂解具有抗性。它对补体经典途径和旁路途径的 IC50值分别为 63 和 12 μM。 | |||
T9316 |
JR14a
5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carbonyl)-l-arginine hydrochloride |
Complement System | Immunology/Inflammation |
JR14a (5-(Bis(4-chlorophenyl)methyl)-3-methylthiophene-2-carbonyl)-l-arginine hydrochloride) 是补体C3a 受体噻吩拮抗剂,可抑制 C3aR 介导的炎症,对人 C3a 受体的选择性高于 C5a 受体。 | |||
T8509 |
Danicopan
ACH-4471 |
Complement System | Immunology/Inflammation |
Danicopan (ACH-4471) 是一种可口服的小分子 D 因子选择性抑制剂,对人 D 因子具有高结合亲和力,Kd 值为 0.54 nM。 它可抑制补体替代途径 (APC) 的活性,具有阻断阵发性夜间血红蛋白尿 (PNH) 和非典型溶血性尿毒症综合征 (aHUS) 的补体替代途径的潜力。 | |||
T9189 |
Iptacopan hydrochloride
Iptacopan HCl,LNP023 hydrochloride |
Complement System | Immunology/Inflammation |
Iptacopan hydrochloride (LNP023 hydrochloride) 是一种可口服、高效和高选择性的因子 B 抑制剂,IC50 为 10 nM。 LNP023 显示与人因子 B 的直接、可逆和高亲和力结合,KD 为 7.9 nM。 | |||
TP1193 |
C3a (70-77) TFA (63555-63-5 free base)
C3a (70-77) TFA,Complement 3a (70-77) (TFA) |
||
C3a (70-77) TFA (Complement 3a (70-77) TFA) is a COOH-terminal fragment of the C3a anaphylatoxin peptide. | |||
T12851 |
SB290157 trifluoroacetate
|
Complement System | Immunology/Inflammation |
SB290157 trifluoroacetate 是一种选择性 C3a 受体拮抗剂,IC50值为200 nM。 | |||
T3638 |
Leukadherin-1
|
Integrin; Complement System | Cytoskeletal Signaling; Immunology/Inflammation |
Leukadherin-1 是 CD11b/CD18 的变构激活剂,可增加 CD11b/CD18 依赖性细胞对纤维蛋白原的粘附,减少白细胞运动和跨内皮迁移,具有抗炎作用。 | |||
T17250 |
W-54011
|
ROS; Complement System | Immunology/Inflammation |
W-54011 是口服有效的非肽 C5a 受体拮抗剂,抑制125I 标记的 C5a 与人嗜中性白细胞的结合,Ki 为 2.2 nM。它还抑制C5a 诱导的人嗜中性粒细胞的细胞内 Ca2+动员,趋化性和ROS 的生成,IC50分别为 3.1 nM、2.7 nM 和1.6 nM。 | |||
T7776 |
ADH-503
GB1275 |
Complement System | Immunology/Inflammation |
ADH-503 (GB1275) 是一种可口服的变构CD11b 激动剂,可以导致与肿瘤相关的巨噬细胞重新极化,可减轻骨髓细胞的免疫抑制,并增强树突状细胞的反应。 | |||
T1076 |
Dexamethasone
MK 125,Prednisolone F,NSC 34521,Hexadecadrol,地塞米松 |
Glucocorticoid Receptor; Mitophagy; IL Receptor; SARS-CoV; Antibacterial; Antibiotic; Autophagy; Complement System | Autophagy; Endocrinology/Hormones; Immunology/Inflammation; Microbiology/Virology |
Dexamethasone (Hexadecadrol) 是一种糖皮质激素受体激动剂和一种 IL 受体调节剂。Dexamethasone 具有抗炎和免疫抑制活性,可诱导自噬。Dexamethasone 抑制 LPS 诱导的巨噬细胞炎症反应。 | |||
T13379 |
(Z)-Leukadherin-1
ADH-503 free base |
Complement System | Immunology/Inflammation |
(Z)-Leukadherin-1 (ADH-503 free base) 是 CD11b 的变构激动剂。 | |||
TP2180L |
Compstatin control peptide acetate
|
Complement System | Immunology/Inflammation |
Compstatin control peptide acetate 是补体蛋白 C3 的抑制剂,通过结合和抑制补体 C3 的切割。 | |||
T76867 |
Ravulizumab
ALXN1210 |
Complement System | Immunology/Inflammation |
Ravulizumab (ALXN1210) 是一种靶向补体因子 5 的人源化单克隆抗体,它以高亲和力特异性结合人补体蛋白 C5,可阻断补体激活。Ravulizumab 可用于预防和治疗阵发性睡眠性血红蛋白尿症、非典型溶血性尿毒症综合征和重症肌无力。 | |||
T12506L1 |
PMX 205 acetate(514814-49-4 free base)
|
Complement System | Immunology/Inflammation |
PMX 205 acetate(514814-49-4 free base) 是补体 C5a 受体 (C5aR; CD88) 的拮抗剂。 | |||
T64388 |
3-Phenoxybenzaldehyde
|
Complement System | Immunology/Inflammation |
3-Phenoxybenzaldehyde 是补体经典途径抑制剂,IC50= 1388μM。 | |||
T76702 |
Sutimlimab
|
Complement System | Immunology/Inflammation |
Sutimlimab 是一种新型靶向补体蛋白 C1 的单克隆抗体。Sutimlimab 常当作 C1 抑制剂使用,用于治疗冷凝集素病相关溶血。 | |||
TP2296L |
TLQP 21 acetate
|
Complement System | Immunology/Inflammation |
TLQP 21 acetate 是 G 蛋白偶联受体补体 3a 受体 1 (C3aR1) 的有效激动剂。 小鼠的 EC50 值为 10.3 μM,人的 EC50 值为 68.8 μM。它是一种 VGF 衍生肽,具有内分泌和内分泌特性。 | |||
T38951 |
Isatuximab
SAR-650984,hu38SB19,Isatuximab-irfc |
Apoptosis; CD38 | Apoptosis; Immunology/Inflammation |
Isatuximab 是一种在血液系统恶性细胞中靶向跨膜受体和胞外酶 CD38 的单克隆抗体,是在多发性骨髓瘤中高度表达的蛋白。Isatuximab 具有抗肿瘤活性、抗体依赖性细胞介导的细胞毒性、补体依赖性细胞毒性、抗体依赖性细胞吞噬作用,可在无交联情况下直接诱导细胞凋亡 (apoptosis)。Isatuximab 对 CD38 胞外酶活性有抑制作用,这与许多细胞功能有关。 | |||
T32353 |
K 76 Carboxylic acid
K76 Carboxylic acid,K-76 Carboxylic acid |
||
K 76 Carboxylic acid effectively blocks human complement from forming tumor cell chemokines. | |||
T12506L |
PMX 205
|
Others | Others |
PMX 205 is an effective complement antagonist of the C5a receptor. | |||
T39493 |
Vemircopan
ACH0145228,ACH-5228,ALXN2050 |
||
Vemircopan is a complement factor D inhibitor. | |||
T12506 |
PMX 205 Trifluoroacetate (514814-49-4 free base)
PMX 205 Trifluoroacetate |
Others | Others |
PMX 205 Trifluoroacetate is a potent complement antagonist of C5a receptor. | |||
T69393 | SID-7977382 | ||
SID-7977382 is a complement factor C1 inhibitor. | |||
T77107 | Olendalizumab | ||
Olendalizumab (ALXN1007)为源自小鼠的人源化IgG2-G4-κ抗体,专一靶向补体蛋白C5a(Ki=60 pM),用于探究冠状病毒引发的补体介导疾病,并针对补体炎症通路。 | |||
T73710 | PMX 205 Trifluoroacetate | ||
PMX 205 Trifluoroacetate 是一种有效的补体C5a 受体 (C5aR;CD88) 拮抗剂。 | |||
T11269 |
FD-IN-1
|
Others | Others |
FD-IN-1 is a factor D (FD) inhibitor with an IC50 of 12 nM.FD-IN-1 also inhibits factor XIa (FXIa) and Tryptase β2 with IC50s of 7.7 and 6.5μM, respectively. Complement FD, a highly specific S1 serine protease, plays a central role in the alternative complement pathway of the innate immune system. | |||
T77121 | Pozelimab | ||
Pozelimab (REGN3918)为一种针对component 5 (C5) 的人源IgG4单克隆抗体。其通过高亲和力结合C5及其变体,有效阻断补体介导的溶血作用,适用于对补体介导疾病进行研究。 | |||
T62276 |
Factor B-IN-3
|
||
Factor B-IN-3 是一种补体因子 B (complement factor B) 的有效抑制剂。Factor B-IN-3 能够用于研究炎症和免疫相关疾病。 | |||
T76913 | Avdoralimab | ||
Avdoralimab (IPH 5401),一种全人IgGκ单克隆抗体,针对补体C5a受体1 (C5aR1),阻碍其与C5a结合。该药物适用于研究补体驱动的炎症性疾病及实体瘤。 | |||
T74431 |
Cemdisiran
|
||
Cemdisiran 是一种 GalNAc 偶联的 siRNA 干扰,通过抑制肝脏补体5 (C5)蛋白的产生来研究补体介导的疾病。 | |||
T76814 | Lampalizumab | ||
Lampalizumab (RG 7417) 为靶向补体通路中补体因子 D (Factor D) 的人源单克隆抗体。通过结合外位点,该药物立体阻断因子 B 进入活性位点,用于老年性黄斑变性 (AMD) 研究。 | |||
TP2139 |
AMY-101
Cp40 |
Others | Others |
AMY-101 TFA (Cp40 TFA) is a peptidic inhibitor of the central complement component C3 (KD: 0.5 nM). It shows a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation. | |||
T62688 |
Factor B-IN-4
|
||
Factor B-IN-4 是一种补体因子 B (complement factor B) 的有效抑制剂 (IC50: 1 μM)。Factor B-IN-4 能够用于研究炎症和免疫相关疾病。 | |||
T62292 |
Factor B-IN-2
|
||
Factor B-IN-2 是一种补体因子 B (complement factor B) 的有效抑制剂 (IC50: 1.5 μM)。Factor B-IN-2 能够用于研究炎症和免疫相关疾病。 | |||
T9695L |
POT-4 acetate
POT-4 acetate (934461-40-2 free base) |
Complement System | Immunology/Inflammation |
POT-4 acetate 抑制 Complement C3 的活化。 POT-4 acetate 可用于年龄相关性黄斑变性的研究。 | |||
TP2139L |
AMY-101 TFA
Cp40 TFA |
Others | Others |
AMY-101 TFA (Cp40 TFA) is a peptidic inhibitor of the central complement component C3 (KD: 0.5 nM). It shows a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation. | |||
T75966 |
C3a (70-77) (TFA)
|
||
C3a (70-77) TFA (Complement 3a (70-77) TFA) 为COOH末端对应C3a的八肽,具有C3a的特异性且生物活性约为1至2%。 | |||
T62689 |
Factor B-IN-5
|
||
Factor B-IN-5 是一种补体因子 B (complement factor B) 的有效抑制剂 (IC50: 1.2 μM)。Factor B-IN-4 能够用于研究炎症和免疫相关疾病。 | |||
T77022 | Gefurulimab | ||
Gefurulimab(ALXN-1720) 是一种人源的抗补体 C5和白蛋白的双特异性抗体,可结合 C5 并阻止其激活。 | |||
T75106 |
ARC186
|
||
ARC 186 是一种核酸适配体,是高效的补体抑制剂,通过阻断转化酶催化的C5 激活发挥作用。 | |||
TP1866 |
β-Amyloid (1-11)
β-amyloid 1-11 |
||
Anionic interaction of Beta-amyloid (1-11) with Factor XII is suspected to cause massive activation of the C4 (complement 4) system in the cerebrospinal fluid of Alzheimer’s disease patients. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0945 |
Cyclosporin A
环孢素,Cyclosporine A,Ciclosporin,Cyclosporine,环孢菌素 |
Phosphatase; Antibiotic; Complement System | Immunology/Inflammation; Metabolism; Microbiology/Virology |
Cyclosporin A 属于天然产物,是一种真菌的活性代谢产物,一种环状多肽。Cyclosporin A 是一种能与亲环素结合的免疫抑制剂,可以抑制 calcineurin (IC50=7 nM)。 | |||
T40646 |
Lipoteichoic acid
|
Complement System | Immunology/Inflammation |
Lipoteichoic acid 是 Staphylococcus aureus 细胞壁的聚合物,通过诱导 C3 和抑制 CD55 来激活补体系统,通过 IGF-1 途径减少脂肪沉积。 | |||
TN3430 |
Apigenin 4'-O-rhamnoside
|
Others | Others |
Apigenin-4'-O-rhamnosylglucoside can strongly inhibit the classical pathway of the complement system. | |||
T83339 |
3β-(Acetyloxy)stigmast-5-en-7-one
|
||
3β-(Acetyloxy)stigmast-5-en-7-one 表现出抗补体活性。 | |||
T82786 | Campneoside II | ||
Campneoside II, 分离自毛泡桐,展现出显著的抗补体活性。 | |||
T80869 |
Versicolactone B
|
||
Versicolactone B,一种从Viola yedoensis分离得到的倍半萜,对经典途径和替代途径均显示出抗补体活性。 | |||
T3S0964 |
Thermopsoside
Chrysoeriol-7-O-glucoside |
Others | Others |
Chrysoeriol-7-O-glucoside can strongly inhibit the classical pathway of the complement system.Chrysoeriol-7-O-d-glucoside and luteolin-7-O-d-glucoside can inhibit palmitic acid uptake into small intestinal brush border membrane, apigenin-7-O-d-glucoside can inhibit alpha-amylase activity; they can enhance norepinephrine-induced lipolysis in fat cells. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00653 |
Complement C5 Protein, Human, Recombinant (Complement C5a)
C5D,C5b,CPAMD4,complement component 5,Complemen... |
Human | E. coli |
C5a is a protein fragment released from complement component C5. This 74 amino acid peptide in humans is generated by the cleavage of C5a convertase on the C5 α-chain during the classical, alternative, and lectin pathways of complement activation. The structure of C5a includes a core region consisting of four, anti-parallel alpha-helices held together by three disulfide linkages and a structured C-terminal tail, and C5a is rapidly metabolised by carboxypeptidase B to a 73 amino acid low activity... | |||
TMPY-04902 |
Complement C5a Protein, Mouse, Recombinant
complement component 5 |
Mouse | E. coli |
C5a is a protein fragment released from complement component C5. This 74 amino acid peptide in humans is generated by the cleavage of C5a convertase on the C5 α-chain during the classical, alternative, and lectin pathways of complement activation. The structure of C5a includes a core region consisting of four, anti-parallel alpha-helices held together by three disulfide linkages and a structured C-terminal tail, and C5a is rapidly metabolised by carboxypeptidase B to a 73 amino acid low activity... | |||
TMPY-05732 |
Complement C3 Protein, Cynomolgus, Recombinant (His)
complement component 3 |
Cynomolgus | HEK293 |
Complement C3 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 with His tag. The predicted molecular weight is 186.40 kDa. Accession number: XP_005587776.1 | |||
TMPY-05057 |
Complement C5 Protein, Human, Recombinant (His & FLAG)
C5b,ECLZB,C5a,CPAMD4,C5D,complement component 5, |
Human | HEK293 |
C5a is a protein fragment released from complement component C5. This 74 amino acid peptide in humans is generated by the cleavage of C5a convertase on the C5 α-chain during the classical, alternative, and lectin pathways of complement activation. The structure of C5a includes a core region consisting of four, anti-parallel alpha-helices held together by three disulfide linkages and a structured C-terminal tail, and C5a is rapidly metabolised by carboxypeptidase B to a 73 amino acid low activity... | |||
TMPY-00686 |
Complement C2 Protein, Human, Recombinant (His)
CO2,complement component 2,ARMD14 |
Human | HEK293 |
Complement component C2 is part of the classical complement pathway which plays a major role in innate immunity against infection. C2 is a glycoprotein synthesized in liver hepatocytes and several other cell types in extrahepatic tissues. This pathway is triggered by a multimolecular complex C1, and subsequently the single-chain form of C2 is cleaved into two chains referred to C2a and C2b by activated C1. The second component of complement (C2) is a multi-domain serine protease that provides ca... | |||
TMPY-05731 |
Complement C3 Protein, Human, Recombinant (His)
HEL-S-62p,CPAMD1,ARMD9,C3b,ASP,C3a,AHUS5,complement... |
Human | HEK293 |
Complement C3 Protein, Human, Recombinant (His) is expressed in HEK293 with His tag. The predicted molecular weight is 186.43 kDa. Accession number: P01024 | |||
TMPY-04921 |
Complement factor B/CFB Protein, Human, Recombinant (His)
ARMD14,GBG,AHUS4,PBF2,complement factor B,FBI12,BF,... |
Human | HEK293 |
Complement factor B/CFB Protein, Human, Recombinant (His) is expressed in HEK293 with His tag. The predicted molecular weight is 84.5 kDa. Accession number: AAH04143.1 | |||
TMPY-02892 |
Complement C7 Protein, Human, Recombinant (His)
Complement C7,complement component 7 |
Human | HEK293 |
Complement component 7 is a component of the complement system. It belongs to the complement C6/C7/C8/C9 family. It contains 1 EGF-like domain, 1 LDL-receptor class A domain, 1 MACPF domain, 2 Sushi (CCP/SCR) domains and 2 TSP type-1 domains. Complement component 7 serves as a membrane anchor. It participates in the formation of Membrane Attack Complex (MAC). People with C7 deficiency are prone to bacterial infection. It is a constituent of MAC that plays a key role in the innate and adaptive im... | |||
TMPY-06538 |
Complement C5 Protein, Cynomolgus, Recombinant
complement component 5 |
Cynomolgus | HEK293 |
C5a is a protein fragment released from complement component C5. This 74 amino acid peptide in humans is generated by the cleavage of C5a convertase on the C5 α-chain during the classical, alternative, and lectin pathways of complement activation. The structure of C5a includes a core region consisting of four, anti-parallel alpha-helices held together by three disulfide linkages and a structured C-terminal tail, and C5a is rapidly metabolised by carboxypeptidase B to a 73 amino acid low activity... | |||
TMPY-03012 |
Complement C7 Protein, Human, Recombinant (hFc)
complement component 7,Complement C7 |
Human | HEK293 |
Complement component 7 is a component of the complement system. It belongs to the complement C6/C7/C8/C9 family. It contains 1 EGF-like domain, 1 LDL-receptor class A domain, 1 MACPF domain, 2 Sushi (CCP/SCR) domains and 2 TSP type-1 domains. Complement component 7 serves as a membrane anchor. It participates in the formation of Membrane Attack Complex (MAC). People with C7 deficiency are prone to bacterial infection. It is a constituent of MAC that plays a key role in the innate and adaptive im... | |||
TMPJ-00417 |
Complement C3a Protein, Human, Recombinant
Anaphylatoxin,C3a,Complement Component C3a |
Human | E. coli |
Complement is defined as key part of innate immunity and as the first line of defense in the fight against invading pathogens. Complement 3 (C3) is the most abundant component of the complement cascade and the convergent point for all three major complement activation pathways: namely classical, alternative and mannose-binding lectin pathways. Complement activation leads to the formation of the C3 convertase, which cleaves C3 into the key effector molecules, C3a (anaphylatoxin) and C3b (opsonin)... | |||
TMPY-02641 |
Complement C6 Protein, Human, Recombinant (His)
complement component 6 |
Human | HEK293 |
Complement C6 Protein, Human, Recombinant (His) is expressed in HEK293 with His tag. The predicted molecular weight is 104 kDa. Accession number: AAA59668.1 | |||
TMPY-06137 |
Complement C5 Protein, Cynomolgus, Recombinant (His)
complement component 5 |
Cynomolgus | HEK293 |
C5a is a protein fragment released from complement component C5. This 74 amino acid peptide in humans is generated by the cleavage of C5a convertase on the C5 α-chain during the classical, alternative, and lectin pathways of complement activation. The structure of C5a includes a core region consisting of four, anti-parallel alpha-helices held together by three disulfide linkages and a structured C-terminal tail, and C5a is rapidly metabolised by carboxypeptidase B to a 73 amino acid low activity... | |||
TMPY-05459 |
Complement C5a Protein, Mouse, Recombinant, Biotinylated
complement component 5 |
Mouse | E. coli |
C5a is a protein fragment released from complement component C5. This 74 amino acid peptide in humans is generated by the cleavage of C5a convertase on the C5 α-chain during the classical, alternative, and lectin pathways of complement activation. The structure of C5a includes a core region consisting of four, anti-parallel alpha-helices held together by three disulfide linkages and a structured C-terminal tail, and C5a is rapidly metabolised by carboxypeptidase B to a 73 amino acid low activity... | |||
TMPY-03447 |
Complement C2 Protein, Mouse, Recombinant (His)
complement component 2 |
Mouse | HEK293 |
Complement component C2 is part of the classical complement pathway which plays a major role in innate immunity against infection. C2 is a glycoprotein synthesized in liver hepatocytes and several other cell types in extrahepatic tissues. This pathway is triggered by a multimolecular complex C1, and subsequently the single-chain form of C2 is cleaved into two chains referred to C2a and C2b by activated C1. The second component of complement (C2) is a multi-domain serine protease that provides ca... | |||
TMPJ-00585 |
Complement C8 gamma Protein, Human, Recombinant (His)
C8 γ,Complement component C8 gamma chain,C8G,Co... |
Human | E. coli |
Complement component C8 is a constituent of the membrane attack complex, C8 alpha, C8 beta and C8G. C8G is a secreted protein and comsists a disulfide-linked C8 alpha-gamma heterodimer and a non-covalently associated C8 beta chain. C8 alpha and C8 beta play an important role in complement-mediated bacterial killing together.C8 is involved in the formation of Membrane Attack Complex on bacterial cell membranes. C8 binds to the C5B-7 complex, forming the C5B-8 complex. C5-B8 binds C9 and acts as a... | |||
TMPJ-00416 |
Complement C3a Protein, Mouse, Recombinant
C3a,Complement Component C3a,Anaphylatoxin |
Mouse | E. coli |
Complement is defined as key part of innate immunity and as the first line of defense in the fight against invading pathogens. Complement 3 (C3) is the most abundant component of the complement cascade and the convergent point for all three major complement activation pathways: namely classical, alternative and mannose-binding lectin pathways. Complement activation leads to the formation of the C3 convertase, which cleaves C3 into the key effector molecules, C3a (anaphylatoxin) and C3b (opsonin)... | |||
TMPH-03270 |
Complement C5 Protein, Rat, Recombinant (His & Myc)
Complement C5,C5 |
Rat | E. coli |
Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.; Derived from proteolytic degradation of complement C5, C5a anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction... | |||
TMPY-06814 |
Complement C5 Protein, Human, Recombinant (Flag)
C5a,CPAMD4,ECLZB,C5b,C5D,Complement C5,compleme... |
Human | HEK293 |
C5a is a protein fragment released from complement component C5. This 74 amino acid peptide in humans is generated by the cleavage of C5a convertase on the C5 α-chain during the classical, alternative, and lectin pathways of complement activation. The structure of C5a includes a core region consisting of four, anti-parallel alpha-helices held together by three disulfide linkages and a structured C-terminal tail, and C5a is rapidly metabolised by carboxypeptidase B to a 73 amino acid low activity... | |||
TMPH-01132 |
Complement C8a Protein, Human, Recombinant (His)
C8A,Complement component 8 subunit alpha,Comple... |
Human | E. coli |
Complement C8a Protein, Human, Recombinant (His) is expressed in E. coli. | |||
TMPH-01134 |
Complement C8g Protein, Human, Recombinant (His)
C8G,Complement component C8 gamma chain |
Human | E. coli |
Complement C8g Protein, Human, Recombinant (His) is expressed in E. coli. | |||
TMPH-01133 |
Complement C8b Protein, Human, Recombinant (His)
Complement component C8 beta chain,C8B,Compleme... |
Human | E. coli |
Complement C8b Protein, Human, Recombinant (His) is expressed in E. coli. | |||
TMPH-03107 |
Complement C5a Protein, Pig, Recombinant (His)
Complement C5a anaphylatoxin,C5 |
Sus scrofa (Pig) | Yeast |
Derived from proteolytic degradation of complement C5, C5a anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | |||
TMPH-02604 |
Complement C3 Protein, Mouse, Recombinant (His & SUMO)
C3,Complement C3 |
Mouse | E. coli |
C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates.; Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. In chronic inflammation, acts as a chemoattractant for neutrophils. It induces t... | |||
TMPY-00687 |
Complement C2 Protein, Human, Recombinant (hFc)
ARMD14,complement component 2,CO2 |
Human | HEK293 |
Complement component C2 is part of the classical complement pathway which plays a major role in innate immunity against infection. C2 is a glycoprotein synthesized in liver hepatocytes and several other cell types in extrahepatic tissues. This pathway is triggered by a multimolecular complex C1, and subsequently the single-chain form of C2 is cleaved into two chains referred to C2a and C2b by activated C1. The second component of complement (C2) is a multi-domain serine protease that provides ca... | |||
TMPH-00231 |
Complement C3 Protein, Bovine, Recombinant (His & SUMO)
Complement C3,C3 |
Bovine | E. coli |
C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregates.; Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and... | |||
TMPY-06767 |
Complement C3 Protein, Mouse, Recombinant (His)
HSE-MSF,complement component 3,Plp,AI255234,ASP |
Mouse | HEK293 |
Complement C3 Protein, Mouse, Recombinant (His) is expressed in HEK293 with His tag. The predicted molecular weight is 36.34 kDa. Accession number: NP_033908.2 | |||
TMPY-04141 |
Complement factor H/CFH Protein, Mouse, Recombinant (hFc)
complement factor H,Sas1,NOM,Mud-1,Sas-1 |
Mouse | HEK293 |
Complement factor H, also known as H factor 1, and CFH, is a sialic acid containing glycoprotein that plays an integral role in the regulation of the complement-mediated immune system that is involved in microbial defense, immune complex processing, and programmed cell death. Factor H protects host cells from injury resulting from unrestrained complement activation. CFH regulates complement activation on self cells by possessing both cofactor activity for the Factor I mediated C3b cleavage, and ... | |||
TMPK-01268 |
Complement C2 Protein, Cynomolgus, Recombinant (His)
C2,CO2,Complement C2,C3/C5 convertase,ARMD14 |
Cynomolgus | HEK293 |
Single nucleotide polymorphism (SNP) of complement component 2 (C2) has been found to be significantly associated with hepatocellular carcinoma (HCC). Significantly lower C2 expression was found at HCC compared to healthy controls, and C2 was associated with TNM stages. Higher C2 expression was significantly associated with better prognosis, and multivariate analysis showed that C2 was also an independent factor for the prognosis of HCC. | |||
TMPH-03273 |
Complement factor I Protein, Rat, Recombinant (His & Myc)
If,Complement factor I,Cfi,C3B/C4B inactivator |
Rat | Baculovirus |
Trypsin-like serine protease that plays an essential role in regulating the immune response by controlling all complement pathways. Inhibits these pathways by cleaving three peptide bonds in the alpha-chain of C3b and two bonds in the alpha-chain of C4b thereby inactivating these proteins. Essential cofactors for these reactions include factor H and C4BP in the fluid phase and membrane cofactor protein/CD46 and CR1 on cell surfaces. The presence of these cofactors on healthy cells allows degrada... | |||
TMPJ-00980 |
Complement Factor MASP3 Protein, Human, Recombinant (His)
PRSS5,CRARF,Serine Protease 5,MASP1,MASP-1,Mannose-Binding L... |
Human | Human Cells |
MASP3 is a member of the MASPs involved in mannan-binding lectin (MBL) complement pathway. The MBL pathway is initiated by the binding of MBL to specific carbohydrate structures found on the surface of a variety of microorganisms. Activation of the complement pathway via MBL is initiated by specific MASPs. Three MASPs have been identified and all have domain structures similar to those of C1r and C1s with a heavy chain (chain A) and a light chain (chain B). Chain A is composed of CUB1, EGF, CUB2... | |||
TMPY-02183 |
Complement Factor D/CFD Protein, Human, Recombinant (His)
PFD,DF,complement factor D (adipsin),ADN,FACTOR D,A... |
Human | HEK293 |
Complement factor D, also known as Adipsin, C3 convertase activator, Properdin factor D and CFD is a secreted protein which belongs to thepeptidase S1 family. CFD / Adipsin contains onepeptidase S1 domain. Complement factor D ( CFD / Adipsin ) is a component of the alternative complement pathway best known for its role in humoral suppression of infectious agents. Complement factor D ( CFD / Adipsin ) has a high level of expression in fat, suggesting a role for adipose tissue in immune sys... | |||
TMPY-04129 |
Complement factor H/CFH Protein, Mouse, Recombinant (His)
Sas-1,Mud-1,NOM,complement factor H,Sas1 |
Mouse | HEK293 |
Complement factor H, also known as H factor 1, and CFH, is a sialic acid containing glycoprotein that plays an integral role in the regulation of the complement-mediated immune system that is involved in microbial defense, immune complex processing, and programmed cell death. Factor H protects host cells from injury resulting from unrestrained complement activation. CFH regulates complement activation on self cells by possessing both cofactor activity for the Factor I mediated C3b cleavage, and ... | |||
TMPY-02167 |
Complement Factor D/CFD Protein, Mouse, Recombinant (His,HEK293)
DF,Adn,complement factor D (adipsin) |
Mouse | HEK293 |
Complement factor D, also known as Adipsin, C3 convertase activator, Properdin factor D and CFD is a secreted protein which belongs to thepeptidase S1 family. CFD / Adipsin contains onepeptidase S1 domain. Complement factor D ( CFD / Adipsin ) is a component of the alternative complement pathway best known for its role in humoral suppression of infectious agents. Complement factor D ( CFD / Adipsin ) has a high level of expression in fat, suggesting a role for adipose tissue in immune sys... | |||
TMPK-00776 |
Complement factor I Protein, Human, Recombinant (His)
FIC3b-INA,KAF,IF,CFI,I factor (complement),EC:3.4.2... |
Human | HEK293 |
Complement factor I (CFI) is a serine protease which plays a key role in the modulation of complement system and the induced-fit factor responsible for controlling the complement-mediated processes. | |||
TMPH-02605 |
Complement C4-B Protein, Mouse, Recombinant (His)
C3 and PZP-like alpha-2-macroglobulin domain-containing prot... |
Mouse | E. coli |
Non-enzymatic component of C3 and C5 convertases and thus essential for the propagation of the classical complement pathway. Covalently binds to immunoglobulins and immune complexes and enhances the solubilization of immune aggregates and the clearance of IC through CR1 on erythrocytes. Catalyzes the transacylation of the thioester carbonyl group to form ester bonds with carbohydrate antigens. | |||
TMPH-02607 |
Complement factor B Protein, Mouse, Recombinant (His)
C3/C5 convertase,Complement factor B,Cfb,Bf,H2-Bf |
Mouse | E. coli |
Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5 convertase. | |||
TMPK-01023 |
Complement factor I Protein, Mouse, Recombinant (His)
FIC3b-INA,I factor (complement),IF,C3B/C4B inactiva... |
Mouse | HEK293 |
Complement factor I (CFI) is a serine protease which plays a key role in the modulation of complement system and the induced-fit factor responsible for controlling the complement-mediated processes. | |||
TMPH-01131 |
Complement C4-B Protein, Human, Recombinant (His & SUMO)
C4B,C3 and PZP-like alpha-2-macroglobulin domain-containing ... |
Human | E. coli |
Complement C4-B Protein, Human, Recombinant (His & SUMO) is expressed in E. coli. | |||
TMPJ-00149 |
Complement Factor D/CFD Protein, Mouse, Recombinant (His)
C3 convertase activator,28 kDa adipocyte protein,Cfd,Adipsin... |
Mouse | Human Cells |
Complement factor D, also known as adipsin, is a member of the chymotrypsin family of serine proteases, which plays an essential role in host defense as the rate-limiting enzyme in the alternative pathway of complement activation. Complement factor D activates a convertase (C3bBb) responsible for cleavage of the complement protein C3, which leads to the activation of terminal complement component C5-9 to form the membrane attack complex on microbial or cellular surfaces. It also functions in the... | |||
TMPH-03272 |
Complement factor D Protein, Rat, Recombinant (His)
Adipsin,Df,Adn,C3 convertase activator,Complement f... |
Rat | Yeast |
Factor D cleaves factor B when the latter is complexed with factor C3b, activating the C3bbb complex, which then becomes the C3 convertase of the alternate pathway. Its function is homologous to that of C1s in the classical pathway. | |||
TMPK-00755 |
Complement Factor D/CFD Protein, Human, Recombinant (hFc)
C3 convertase activator,DF,AMBP-1,EC 3.4.21,EC 3.4.21.46,Adi... |
Human | HEK293 |
Complement factor D is a serine protease essential for the activation of the alternative pathway and is expressed in the kidney, adipocytes, and macrophages. Factor D is found at relatively high levels in glomeruli suggesting that this component of the complement cascade could influence renal pathophysiology.Complement factor D or alternative pathway activation is needed to prevent spontaneous accumulation of C3 and IgM deposits within the mesangium. | |||
TMPH-03271 |
Complement factor D Protein, Rat, Recombinant (His & Myc)
Adn,C3 convertase activator,Properdin factor D,Complemen... |
Rat | HEK293 |
Factor D cleaves factor B when the latter is complexed with factor C3b, activating the C3bbb complex, which then becomes the C3 convertase of the alternate pathway. Its function is homologous to that of C1s in the classical pathway. | |||
TMPK-00151 |
Complement Factor D/CFD Protein, Mouse, Recombinant (hFc)
C3 convertase activator,AMBP-1,PFD,FACTOR D,CFD,ADN,EC 3.4.2... |
Mouse | HEK293 |
Complement factor D is a serine protease essential for the activation of the alternative pathway and is expressed in the kidney, adipocytes, and macrophages. Factor D is found at relatively high levels in glomeruli suggesting that this component of the complement cascade could influence renal pathophysiology.Complement factor D or alternative pathway activation is needed to prevent spontaneous accumulation of C3 and IgM deposits within the mesangium. | |||
TMPK-00671 |
Complement Factor D/CFD Protein, Rhesus macaque, Recombinant (His)
Adipsin,CFD,ADN,Complement factor D,DF,AMBP-1,EC 3.... |
Rhesus macaque | HEK293 |
Complement factor D is a serine protease essential for the activation of the alternative pathway and is expressed in the kidney, adipocytes, and macrophages. Factor D is found at relatively high levels in glomeruli suggesting that this component of the complement cascade could influence renal pathophysiology.Complement factor D or alternative pathway activation is needed to prevent spontaneous accumulation of C3 and IgM deposits within the mesangium. | |||
TMPK-00790 |
Complement factor H/CFH Protein, Human, Recombinant (His)
ARMD4,AHUS1,H factor 1,HF1,AMBP1,FH,FHL1,HUS,CFHL3,ARMS1,HF2... |
Human | HEK293 |
Factor H is the major soluble inhibitor of complement, where its binding to self markers (i.e., particular glycan structures) prevents complement activation and amplification on host surfaces. Not surprisingly, mutations and polymorphisms that affect recognition of self by factor H are associated with diseases of complement dysregulation, such as age-related macular degeneration and atypical haemolytic uremic syndrome. In addition, pathogens (i.e., non-self) and cancer cells (i.e., altered-self)... | |||
TMPJ-00809 |
CFH Protein, Human, Recombinant (His)
CFH,Complement factor H |
Human | Human Cells |
Complement Factor H (CFH) is a secreted protein which is a member of the regulators of complement activation family and is a complement control protein. It is expressed by the liver and secreted in plasma. Its principal function is to regulate the Alternative Pathway of the complement system, ensuring that the complement system is directed towards pathogens or other dangerous material and does not damage host tissue. Factor H regulates complement activation on self cells and surfaces by possessi... | |||
TMPH-02603 |
C1SB Protein, Mouse, Recombinant (His & Myc)
C1sb,C1s,Gm5077,Complement C1s-1 subcomponent,C... |
Mouse | E. coli |
C1s B chain is a serine protease that combines with C1q and C1r to form C1, the first component of the classical pathway of the complement system. C1r activates C1s so that it can, in turn, activate C2 and C4. | |||
TMPH-02602 |
C1RA Protein, Mouse, Recombinant (His & Myc)
Complement component 1 subcomponent r-A,C1ra,C1r, |
Mouse | E. coli |
C1r B chain is a serine protease that combines with C1q and C1s to form C1, the first component of the classical pathway of the complement system. | |||
TMPH-02597 |
C1QA Protein, Mouse, Recombinant (His)
Complement C1q subcomponent subunit A,C1QA |
Mouse | Yeast |
C1q associates with the proenzymes C1r and C1s to yield C1, the first component of the serum complement system. The collagen-like regions of C1q interact with the Ca(2+)-dependent C1r(2)C1s(2) proenzyme complex, and efficient activation of C1 takes place on interaction of the globular heads of C1q with the Fc regions of IgG or IgM antibody present in immune complexes. | |||
------------------------ 更多 ------------------------ |